The Ensign Group, Inc. $ENSG Shares Acquired by Grandeur Peak Global Advisors LLC

Grandeur Peak Global Advisors LLC boosted its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 24.6% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 20,924 shares of the company’s stock after acquiring an additional 4,133 shares during the quarter. The Ensign Group accounts for about 0.8% of Grandeur Peak Global Advisors LLC’s portfolio, making the stock its 26th biggest holding. Grandeur Peak Global Advisors LLC’s holdings in The Ensign Group were worth $3,354,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in The Ensign Group by 9.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after purchasing an additional 230 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in The Ensign Group by 65.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after buying an additional 213 shares in the last quarter. Amundi lifted its stake in The Ensign Group by 480,216.7% in the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after buying an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. boosted its holdings in The Ensign Group by 26.1% in the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after buying an additional 421 shares during the last quarter. Hedge funds and other institutional investors own 96.12% of the company’s stock.

The Ensign Group Price Performance

Shares of ENSG stock opened at $172.98 on Monday. The Ensign Group, Inc. has a 12 month low of $141.58 and a 12 month high of $218.00. The company has a market capitalization of $10.08 billion, a PE ratio of 27.11, a price-to-earnings-growth ratio of 1.66 and a beta of 0.68. The firm’s 50-day moving average is $173.40 and its two-hundred day moving average is $184.11. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.21 and a quick ratio of 1.21.

The Ensign Group (NASDAQ:ENSG) last posted its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.12. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.44 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The firm’s quarterly revenue was up 16.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Analysts predict that The Ensign Group, Inc. will post 6.93 earnings per share for the current year.

The Ensign Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th were paid a $0.065 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The Ensign Group’s payout ratio is presently 4.08%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Wall Street Zen lowered The Ensign Group from a “buy” rating to a “hold” rating in a research note on Saturday, July 25th. Weiss Ratings downgraded The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Royal Bank Of Canada reissued an “outperform” rating and issued a $228.00 price objective on shares of The Ensign Group in a research note on Tuesday, July 28th. Finally, Truist Financial raised their price objective on The Ensign Group from $202.00 to $207.00 and gave the company a “hold” rating in a report on Thursday, July 30th. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, The Ensign Group has a consensus rating of “Moderate Buy” and a consensus price target of $216.25.

Insider Buying and Selling at The Ensign Group

In related news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total value of $114,996.00. Following the sale, the director owned 21,352 shares in the company, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total value of $67,055.52. Following the transaction, the director directly owned 9,503 shares in the company, valued at approximately $1,625,583.18. The trade was a 3.96% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is currently owned by insiders.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.